181 related articles for article (PubMed ID: 33707587)
1. MicroRNA-205-5p inhibits skin cancer cell proliferation and increase drug sensitivity by targeting TNFAIP8.
Ge X; Niture S; Lin M; Cagle P; Li PA; Kumar D
Sci Rep; 2021 Mar; 11(1):5660. PubMed ID: 33707587
[TBL] [Abstract][Full Text] [Related]
2. miR-216b enhances the efficacy of vemurafenib by targeting Beclin-1, UVRAG and ATG5 in melanoma.
Luo M; Wu L; Zhang K; Wang H; Wu S; O'Connell D; Gao T; Zhong H; Yang Y
Cell Signal; 2018 Jan; 42():30-43. PubMed ID: 28982601
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-9 inhibits the gastric cancer cell proliferation by targeting TNFAIP8.
Gao HY; Huo FC; Wang HY; Pei DS
Cell Prolif; 2017 Apr; 50(2):. PubMed ID: 28127811
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-148b Inhibits the Malignant Biological Behavior of Melanoma by Reducing Sirtuin 7 Expression Levels.
Sun R; Guo M; Fan X; Meng Q; Yuan D; Yang X; Yan K; Deng H
Biomed Res Int; 2020; 2020():9568976. PubMed ID: 33274232
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-99b-5p targets mTOR/AR axis, induces autophagy and inhibits prostate cancer cell proliferation.
Niture S; Tricoli L; Qi Q; Gadi S; Hayes K; Kumar D
Tumour Biol; 2022; 44(1):107-127. PubMed ID: 35811549
[TBL] [Abstract][Full Text] [Related]
6. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
[TBL] [Abstract][Full Text] [Related]
7. Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B.
Xu H; Hu Y; Qiu W
Biomed Pharmacother; 2017 Mar; 87():405-411. PubMed ID: 28068630
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome and Proteome Analyses of TNFAIP8 Knockdown Cancer Cells Reveal New Insights into Molecular Determinants of Cell Survival and Tumor Progression.
Day TF; Mewani RR; Starr J; Li X; Chakravarty D; Ressom H; Zou X; Eidelman O; Pollard HB; Srivastava M; Kasid UN
Methods Mol Biol; 2017; 1513():83-100. PubMed ID: 27807832
[TBL] [Abstract][Full Text] [Related]
9. Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes.
Shi TY; Cheng X; Yu KD; Sun MH; Shao ZM; Wang MY; Zhu ML; He J; Li QX; Chen XJ; Zhou XY; Wu X; Wei Q
Carcinogenesis; 2013 Apr; 34(4):770-8. PubMed ID: 23299407
[TBL] [Abstract][Full Text] [Related]
10. Decoupling tumor cell metastasis from growth by cellular pilot protein TNFAIP8.
Li M; Li X; Goldsmith JR; Shi S; Zhang L; Zamani A; Wan L; Sun H; Li T; Yu J; Etwebi Z; Bou-Dargham MJ; Chen YH
Oncogene; 2021 Nov; 40(46):6456-6468. PubMed ID: 34608264
[TBL] [Abstract][Full Text] [Related]
11. miR-183-5p functions as a tumor suppressor in lung cancer through PIK3CA inhibition.
Meng F; Zhang L
Exp Cell Res; 2019 Jan; 374(2):315-322. PubMed ID: 30528264
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis.
Wang L; Hou S; Li J; Tian T; Hu R; Yu N
Bioengineered; 2022 Jan; 13(1):1209-1223. PubMed ID: 34982022
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-28-5p regulates glioma cell proliferation, invasion and migration by targeting SphK1.
Chen HS; Lu AQ; Yang PY; Liang J; Wei Y; Shang YW; Li Q
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6621-6628. PubMed ID: 31378904
[TBL] [Abstract][Full Text] [Related]
14. miR-17-5p drives G2/M-phase accumulation by directly targeting CCNG2 and is related to recurrence of head and neck squamous cell carcinoma.
Huang Q; Shen YJ; Hsueh CY; Guo Y; Zhang YF; Li JY; Zhou L
BMC Cancer; 2021 Oct; 21(1):1074. PubMed ID: 34598688
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-340 inhibits squamous cell carcinoma cell proliferation, migration and invasion by downregulating RhoA.
Wang H; Guo W; Jian Q; Xue K; Huang M; Chi S; Li C; Li C
J Dermatol Sci; 2018 Nov; 92(2):197-206. PubMed ID: 30262127
[TBL] [Abstract][Full Text] [Related]
16. miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer.
Wang J; Wang S; Zhou J; Qian Q
Biomed Pharmacother; 2018 Jun; 102():147-152. PubMed ID: 29550638
[TBL] [Abstract][Full Text] [Related]
17. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
18. MiR-93-5p up-regulation is involved in non-small cell lung cancer cells proliferation and migration and poor prognosis.
Yang W; Bai J; Liu D; Wang S; Zhao N; Che R; Zhang H
Gene; 2018 Mar; 647():13-20. PubMed ID: 29309884
[TBL] [Abstract][Full Text] [Related]
19. miR-550a-3-5p acts as a tumor suppressor and reverses BRAF inhibitor resistance through the direct targeting of YAP.
Choe MH; Yoon Y; Kim J; Hwang SG; Han YH; Kim JS
Cell Death Dis; 2018 May; 9(6):640. PubMed ID: 29844307
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic Role of Tumor Necrosis Factor α-Induced Protein 8 (TNFAIP8).
Niture S; Dong X; Arthur E; Chimeh U; Niture SS; Zheng W; Kumar D
Cells; 2018 Dec; 8(1):. PubMed ID: 30586922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
